血液スクリーニングの世界市場予測:技術別(核酸増幅、(リアルタイムPCR)、ELISA(化学発光免疫測定法)、迅速検査、ウエスタンブロット)、製品別(機器、試薬&キット、ソフトウェア)、エンドユーザー別(血液銀行、病院)

◆英語タイトル:Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2025
◆商品コード:MD 3687
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年6月25日
◆ページ数:239
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarkets社は血液スクリーニングの世界市場が2020年19億ドルから2025年35億ドルまで、年平均12.8%成長すると見込んでいます。本調査レポートでは、血液スクリーニングの世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(試薬&キット、器具、ソフトウェア・サービス)分析、技術別(核酸テスト、酵素免疫測定法、迅速型テスト、ウエスタンブロットアッセイ、次世代シーケンシング)分析、エンドユーザー別(血液バンク、病院)分析、地域別分析、競争状況、企業概要などを含めています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・血液スクリーニングの世界市場規模:製品・サービス別(試薬&キット、器具、ソフトウェア・サービス)
・血液スクリーニングの世界市場規模:技術別(核酸テスト、酵素免疫測定法、迅速型テスト、ウエスタンブロットアッセイ、次世代シーケンシング)
・血液スクリーニングの世界市場規模:エンドユーザー別(血液バンク、病院)
・血液スクリーニングの世界市場規模:地域別
・競争状況
・企業概要
【レポートの概要】

“Increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are driving the overall growth of the blood screening market”
The blood screening market is projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 12.8%. Growth in this market is driven by the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens. Technological advancements and developing economies are expected to present opportunities for growth for players in the blood screening market. However, the need to reduce blood screening prices is a major factor in challenging market growth.

“Attractive Opportunities in the Blood Screening Market (2020- 2025)”
COVID-19 Impact Analysis (2020-2025)
COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020. This pandemic has disrupted growth in many economies across various domains. COVID-19 outbreak led to curfews and lockdown worldwide, leading to stalled blood donations, decreased/ cancelled collection drives, reduced demand for donated blood and has adversely affected the growth of blood screening market during the forecasted period globally. As stringencies with respect to curfews and social distancing become more liberal, the demand is expected to grow creating a deficit in the market. However, governments globally are taking initiatives to increase the donation during the forecasted period, to meet the sudden rise in demand following the lockdown.

“Market Dynamics”
Globally, the demand for donated blood is rising because of advancements in healthcare systems and the availability of and need for sophisticated surgical procedures, such as cardiovascular and transplant surgery, trauma care, and therapy for cancer and blood diseases. Blood transfusion is usually prescribed in complicated childbirths to prepare for childhood acute anaemia, trauma, and congenital maternal blood disorders. Road traffic accidents are another important consideration; blood transfusions are often required in the treatment of injuries arising out of road accidents. Moreover, rising prevalence of infectious diseases is another major factor driving the demand for effective blood screening (due to the risk of disease transmission during blood transfusion). Rising incidences of such factors are expected to drive the demand for blood transfusions and thereby will drive the growth for blood screening market.
Emerging markets such as India, China, and Southeast Asia offer promising opportunities for the players in the blood screening industry due to their increasing disposable incomes and improving healthcare infrastructure.
However, even though NAT is a superior and most reliable technology available across the globe, it is the most expensive technique in this market. Hence the emerging economies and low- income economies rely on ELISA over NAT. This is a major inhibitor for the growth of the blood screening market for NAT in the current timeframe.

“Nucleic Acid Testing (NAT) segment accounted for the larger share of the blood screening market, by technology, in 2019”
The blood screening market, by technology, has been segmented into nucleic acid testing (NAT), enzyme-linked immunosorbent assays (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). The NAT segment dominates the blood screening market, by technology, primarily due to the increasing number of blood donations and the increasing adoption of NAT technology due to its higher sensitivity over other blood screening technologies. Based on type, the blood screening market for NAT is segmented into transcription-mediated amplification (TMA) and real-time PCR. Among these, the TMA segment accounts for the larger market share due to the higher sensitivity of this assay.

“Blood banks to register the highest growth in the blood screening market during the forecast period”
Based on end users, the blood screening market is segmented into blood banks and hospitals. The blood bank segment accounted for the larger market share in 2019 and is projected to witness a higher growth rate during the forecast period. This can be attributed to the increasing demand for donated blood, a growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, increasing the number of donations worldwide, and growth in government funding to charitable trusts.

“North America will continue to dominate the blood screening market during the forecast period”
Based on region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest market share, followed by Europe. Factors such as the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens, the presence of high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the blood screening market in North America.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 36%, Tier 2 – 45%, and Tier 3 – 19%
• By Designation: C-level – 33%, D-level – 40%, and Others – 27%
• By Region: North America – 39%, Europe – 28%, Asia Pacific – 19%, Latin America- 9% and the Middle East and Africa- 5%

Top 5 players in the blood screening market (2020- 2025)
• F. Hoffmann-La Roche AG (Switzerland)
• Grifols (Spain)
• Abbott Laboratories (US)
• BioMérieux (France)
• Bio-Rad Laboratories (US)

Companies Profiled in the Report:
Prominent players in the blood screening market include Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioMérieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical Diagnostics, Inc. (US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India).

Research Coverage:
This report provides a detailed picture of the global blood screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, technology, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall blood screening market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, opportunities, and trends.

Frequently asked questions:
• Where will these developments take the industry in the mid-to-long term?
• What are the recent trends affecting the blood screening market?
• Who are the key players in the market, and how intense is the competition?
• What are the key applications of blood screening instruments and consumables?
• Which region is lucrative for the blood screening market?

【レポートの目次】

1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
TABLE 1 INCLUSIONS & EXCLUSIONS 42
1.3 MARKET SCOPE 43
1.3.1 MARKETS COVERED 43
1.3.2 YEARS CONSIDERED FOR THE STUDY 43
1.4 CURRENCY 44
1.5 LIMITATIONS 44
1.6 STAKEHOLDERS 44

2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
2.2 RESEARCH DESIGN 45
2.2.1 SECONDARY DATA 46
2.2.1.1 Secondary sources 46
2.2.2 PRIMARY DATA 47
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 47
2.3 MARKET SIZE ESTIMATION 48
2.3.1 BOTTOM-UP APPROACH 48
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 49
2.3.2 TOP-DOWN APPROACH 49
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 49
2.3.3 GROWTH FORECAST 50
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 50
FIGURE 4 DATA TRIANGULATION METHODOLOGY 50
2.5 ASSUMPTIONS FOR THE STUDY 51

3 EXECUTIVE SUMMARY 52
FIGURE 5 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025
(USD MILLION) 52
FIGURE 6 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020 VS. 2025
(USD MILLION) 53
FIGURE 7 BLOOD SCREENING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 53
FIGURE 8 BLOOD SCREENING MARKET, BY REGION, 2020 VS. 2025 (USD MILLION) 54

4 PREMIUM INSIGHTS 55
4.1 BLOOD SCREENING MARKET OVERVIEW 55
FIGURE 9 INCREASING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES TO DRIVE MARKET GROWTH 55
4.2 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD BILLION) 55
FIGURE 10 REAGENTS & KITS SEGMENT DOMINATES THE BLOOD SCREENING MARKET 55
4.3 BLOOD SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
FIGURE 11 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 56

5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
5.2.1 DRIVERS 57
5.2.1.1 Increasing demand for donated blood and rising number of blood donations 57
TABLE 2 GLOBAL CANCER INCIDENCE, 2018 VS. 2025 58
5.2.1.2 Rising prevalence of infectious diseases and the emergence of newer pathogens 58
5.2.2 OPPORTUNITIES 59
5.2.2.1 Technological advancements 59
5.2.2.2 Emerging economies 59
5.2.3 CHALLENGES 60
5.2.3.1 Need for reducing blood screening prices 60
5.3 COVID-19 IMPACT ON THE BLOOD SCREENING MARKET 60
5.4 ADJACENT MARKETS 61
TABLE 3 ADJACENT MARKETS FOR BLOOD SCREENING MARKET (USD MILLION) 61

6 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE 62
6.1 INTRODUCTION 63
TABLE 4 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019
(USD MILLION) 63
TABLE 5 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025
(USD MILLION) 63
6.2 REAGENTS & KITS 64
TABLE 6 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION) 64
TABLE 7 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION) 64
TABLE 8 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 65
TABLE 9 BLOOD SCREENING MARKET, REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 65
6.2.1 NAT REAGENTS & KITS 65
6.2.1.1 High sensitivity and rising use of NAT are boosting demand for related reagents and kits 65
TABLE 10 NAT REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION) 66
TABLE 11 NAT REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION) 66
TABLE 12 NAT REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 66
TABLE 13 NAT REAGENTS & KITS MARKET, BY TYPE, 2021–2025 (USD MILLION) 67
6.2.1.2 Enzymes & polymerases 67
6.2.1.3 Standards & controls 67
6.2.1.4 Probes & primers 67
6.2.1.5 Buffers, nucleotides, and solutions 67
6.2.1.6 Labeling & detection reagents 67
6.2.2 ELISA REAGENTS & KITS 68
6.2.2.1 Ease of use and cost-effectiveness of ELISA reagents & kits will drive market growth 68
TABLE 14 ELISA REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION) 68
TABLE 15 ELISA REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION) 68
TABLE 16 ELISA REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 69
TABLE 17 ELISA REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 69
6.2.2.2 Immunosorbents 69
6.2.2.3 Controls 69
6.2.2.4 Conjugates 69
6.2.2.5 Substrates 70
6.2.2.6 Sample diluents & wash solutions 70
6.2.3 OTHER REAGENTS & KITS 70
6.2.3.1 Increasing use of western blot tests and rapid tests will drive the growth of this market segment 70
TABLE 18 OTHER REAGENTS & KITS MARKET, BY REGION, 2018–2020 (USD MILLION) 70
TABLE 19 OTHER REAGENTS & KITS MARKET, BY REGION, 2020–2025 (USD MILLION) 71
6.3 INSTRUMENTS 71
TABLE 20 BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2016–2019
(USD MILLION) 71
TABLE 21 BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2020–2025
(USD MILLION) 72
TABLE 22 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE,
2016–2019 (USD MILLION) 72
TABLE 23 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE,
2020–2025 (USD MILLION) 72
6.3.1 RENTAL PURCHASE 73
6.3.1.1 Convenience and cost-effectiveness of renting instruments has resulted in a greater end-user preference 73
TABLE 24 MARKET FOR RENTAL PURCHASE OF BLOOD SCREENING INSTRUMENTS,
BY REGION, 2016–2019 (USD MILLION) 73
TABLE 25 MARKET FOR RENTAL PURCHASE OF BLOOD SCREENING INSTRUMENTS,
BY REGION, 2020–2025 (USD MILLION) 73
6.3.2 OUTRIGHT PURCHASE 74
6.3.2.1 Availability of government support will increase the outright purchase of instruments 74
TABLE 26 MARKET FOR OUTRIGHT PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2016–2019 (USD MILLION) 74
TABLE 27 MARKET FOR OUTRIGHT PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2020–2025 (USD MILLION) 74
6.4 SOFTWARE & SERVICES 75
6.4.1 INCREASING ADOPTION OF INSTRUMENTS WILL DRIVE THE DEMAND FOR RELATED SOFTWARE AND SERVICES 75
TABLE 28 BLOOD SCREENING SOFTWARE & SERVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 75
TABLE 29 BLOOD SCREENING SOFTWARE & SERVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 75

7 BLOOD SCREENING MARKET, BY TECHNOLOGY 76
7.1 INTRODUCTION 77
TABLE 30 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION) 77
TABLE 31 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 77
7.2 NUCLEIC ACID TESTING 77
TABLE 32 BLOOD SCREENING MARKET FOR NAT, BY REGION, 2016–2019
(USD MILLION) 78
TABLE 33 BLOOD SCREENING MARKET FOR NAT, BY REGION, 2020–2025
(USD MILLION) 78
TABLE 34 BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION) 79
TABLE 35 BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION) 79
7.2.1 TRANSCRIPTION-MEDIATED AMPLIFICATION 79
7.2.1.1 High sensitivity of these assays to support market growth 79
TABLE 36 TRANSCRIPTION-MEDIATED AMPLIFICATION MARKET, BY REGION, 2016–2019 (USD MILLION) 80
TABLE 37 TRANSCRIPTION-MEDIATED AMPLIFICATION MARKET, BY REGION, 2020–2025 (USD MILLION) 80
7.2.2 REAL-TIME POLYMERASE CHAIN REACTION 80
7.2.2.1 Real-time PCR procedures provide more accurate and effective results as compared to conventional PCR 80
TABLE 38 REAL-TIME PCR MARKET, BY REGION, 2016–2019 (USD MILLION) 81
TABLE 39 REAL-TIME PCR MARKET, BY REGION, 2020–2025 (USD MILLION) 81
7.3 ENZYME-LINKED IMMUNOSORBENT ASSAY 81
TABLE 40 BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2016–2019
(USD MILLION) 82
TABLE 41 BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2020—2025
(USD MILLION) 82
TABLE 42 BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016—2019
(USD MILLION) 83
TABLE 43 BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025
(USD MILLION) 83
7.3.1 CHEMILUMINESCENCE IMMUNOASSAY 83
7.3.1.1 CLIA is ultrasensitive, automated, and a good alternative to conventional methodologies 83
TABLE 44 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2016–2019 (USD MILLION) 84
TABLE 45 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2020–2025 (USD MILLION) 84
7.3.2 FLUORESCENT IMMUNOASSAY 84
7.3.2.1 Rising demand for safer and stable reagents and the development of novel markers to support the growth of this market segment 84
TABLE 46 FLUORESCENT IMMUNOASSAYS MARKET, BY REGION, 2016–2019
(USD MILLION) 85
TABLE 47 FLUORESCENT IMMUNOASSAYS MARKET, BY REGION, 2020–2025
(USD MILLION) 85
7.3.3 COLORIMETRIC IMMUNOASSAYS 85
7.3.3.1 CI offers low sensitivity as it uses vulnerable/limited signal amplification strategies 85
TABLE 48 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2016–2019
(USD MILLION) 86
TABLE 49 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2020–2025
(USD MILLION) 86
7.4 RAPID TESTS 86
7.4.1 RISING AWARENESS ABOUT RAPID TESTS IN EMERGING COUNTRIES TO DRIVE MARKET GROWTH 86
TABLE 50 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2016–2019 (USD MILLION) 87
TABLE 51 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2020–2025 (USD MILLION) 87
7.5 WESTERN BLOT ASSAYS 87
7.5.1 GROWING PREVALENCE OF TTIS IN DEVELOPING COUNTRIES HAS RESULTED IN THE INCREASED DEMAND FOR WESTERN BLOT ASSAYS 87
TABLE 52 BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2016–2019 (USD MILLION) 88
TABLE 53 BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2020–2025 (USD MILLION) 88
7.6 NEXT-GENERATION SEQUENCING 89
7.6.1 NGS IS AN EMERGING TECHNOLOGY IN THE BLOOD SCREENING MARKET 89
TABLE 54 BLOOD SCREENING MARKET FOR NGS, BY REGION, 2016–2019
(USD MILLION) 89
TABLE 55 BLOOD SCREENING MARKET FOR NGS, BY REGION, 2020–2025
(USD MILLION) 89

8 BLOOD SCREENING MARKET, BY END USER 90
8.1 INTRODUCTION 91
TABLE 56 BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 91
TABLE 57 BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 91
8.2 BLOOD BANKS 91
8.2.1 BLOOD BANKS HOLD THE LARGEST SHARE OF THE BLOOD SCREENING MARKET 91
TABLE 58 BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2016–2019 (USD MILLION) 92
TABLE 59 BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2020–2025 (USD MILLION) 92
8.3 HOSPITALS 92
8.3.1 INCREASING G NUMBER OF SURGICAL PROCEDURES WILL DRIVE THE GROWTH OF THE HOSPITALS SEGMENT 92
TABLE 60 BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2016–2019
(USD MILLION) 93
TABLE 61 BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2020–2025
(USD MILLION) 93

9 BLOOD SCREENING MARKET, BY REGION 94
9.1 INTRODUCTION 95
TABLE 62 BLOOD SCREENING MARKET, BY REGION, 2016–2019 (USD MILLION) 95
TABLE 63 BLOOD SCREENING MARKET, BY REGION, 2020–2025 (USD MILLION) 95
9.2 NORTH AMERICA 96
FIGURE 12 NORTH AMERICA: BLOOD SCREENING MARKET SNAPSHOT 96
TABLE 64 NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 97
TABLE 65 NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 97
TABLE 66 NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY,
2016–2019 (USD MILLION) 97
TABLE 67 NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 98
TABLE 68 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE,
2016–2019 (USD MILLION) 98
TABLE 69 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE,
2020–2025 (USD MILLION) 98
TABLE 70 NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 99
TABLE 71 NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 99
TABLE 72 NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 99
TABLE 73 NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 100
TABLE 74 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 100
TABLE 75 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 100
TABLE 76 NORTH AMERICA: BLOOD SCREENING INSTRUMENTS MARKET,
BY PURCHASE TYPE, 2016–2019 (USD MILLION) 101
TABLE 77 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 101
TABLE 78 NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 101
TABLE 79 NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 101
9.2.1 US 102
9.2.1.1 The US dominates the global blood screening market 102
9.2.1.2 COVID-19 Impact Analysis 102
TABLE 80 INCIDENCE OF VARIOUS CANCERS IN THE US, 2018 VS. 2025 102
TABLE 81 US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 103
TABLE 82 US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 103
TABLE 83 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 103
TABLE 84 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 104
TABLE 85 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 104
TABLE 86 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 104
TABLE 87 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 104
TABLE 88 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 105
TABLE 89 US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 105
TABLE 90 US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 105
TABLE 91 US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 105
TABLE 92 US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 106
TABLE 93 US: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 106
TABLE 94 US: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 106
9.2.2 CANADA 106
9.2.2.1 Growing volume of surgical procedures performed and the high burden of cancer to support market growth 106
9.2.2.2 COVID-19 Impact Analysis 107
TABLE 95 CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 107
TABLE 96 CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 107
TABLE 97 CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 108
TABLE 98 CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 108
TABLE 99 CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2016–2019 (USD MILLION) 108
TABLE 100 CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2020–2025 (USD MILLION) 108
TABLE 101 CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 109
TABLE 102 CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 109
TABLE 103 CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 109
TABLE 104 CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 110
TABLE 105 CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 110
TABLE 106 CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 110
TABLE 107 CANADA: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 110
TABLE 108 CANADA: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 111
9.3 EUROPE 111
TABLE 109 EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019
(USD MILLION) 111
TABLE 110 EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025
(USD MILLION) 112
TABLE 111 EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 112
TABLE 112 EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 112
TABLE 113 EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 113
TABLE 114 EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 113
TABLE 115 EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2016–2019 (USD MILLION) 113
TABLE 116 EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2020–2025 (USD MILLION) 113
TABLE 117 EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 114
TABLE 118 EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 114
TABLE 119 EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 114
TABLE 120 EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 115
TABLE 121 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 115
TABLE 122 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 115
TABLE 123 EUROPE: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 115
TABLE 124 EUROPE: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 116
9.3.1 GERMANY 116
9.3.1.1 Germany is the largest market for blood screening technologies in Europe 116
9.3.1.2 COVID-19 Impact Analysis 116
TABLE 125 GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION) 116
TABLE 126 GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 117
TABLE 127 GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION) 117
TABLE 128 GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION) 117
TABLE 129 GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2016–2019 (USD MILLION) 117
TABLE 130 GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2020–2025 (USD MILLION) 118
TABLE 131 GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 118
TABLE 132 GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 118
TABLE 133 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 119
TABLE 134 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 119
TABLE 135 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 119
TABLE 136 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 120
TABLE 137 GERMANY: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 120
TABLE 138 GERMANY: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 120
9.3.2 FRANCE 120
9.3.2.1 Increasing prevalence of HIV to support market growth 120
TABLE 139 FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 121
TABLE 140 FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 121
TABLE 141 FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 121
TABLE 142 FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 122
TABLE 143 FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2016–2019 (USD MILLION) 122
TABLE 144 FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2020–2025 (USD MILLION) 122
TABLE 145 FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 123
TABLE 146 FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 123
TABLE 147 FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 123
TABLE 148 FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 124
TABLE 149 FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 124
TABLE 150 FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 124
TABLE 151 FRANCE: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 124
TABLE 152 FRANCE: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 125
9.3.3 UK 125
9.3.3.1 Government support to prevent transmission of HIV and other infections will drive market growth 125
9.3.3.2 COVID-19 Impact Analysis 125
TABLE 153 UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 126
TABLE 154 UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 126
TABLE 155 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 126
TABLE 156 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 127
TABLE 157 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 127
TABLE 158 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 127
TABLE 159 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 127
TABLE 160 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 128
TABLE 161 UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 128
TABLE 162 UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 128
TABLE 163 UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE,
2016–2019 (USD MILLION) 128
TABLE 164 UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE,
2020–2025 (USD MILLION) 129
TABLE 165 UK: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 129
TABLE 166 UK: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 129
9.3.4 ITALY 129
9.3.4.1 Italy is witnessing an increase in the number of blood donors 129
9.3.4.2 COVID-19 Impact Analysis 130
TABLE 167 ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 130
TABLE 168 ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 130
TABLE 169 ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 130
TABLE 170 ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 131
TABLE 171 ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 131
TABLE 172 ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 131
TABLE 173 ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 132
TABLE 174 ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 132
TABLE 175 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 132
TABLE 176 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 133
TABLE 177 ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 133
TABLE 178 ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 133
TABLE 179 ITALY: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 133
TABLE 180 ITALY: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 134
9.3.5 SPAIN 134
9.3.5.1 Increasing adoption of NAT technology will support market growth 134
TABLE 181 SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 134
TABLE 182 SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 135
TABLE 183 SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 135
TABLE 184 SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 135
TABLE 185 SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 135
TABLE 186 SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 136
TABLE 187 SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 136
TABLE 188 SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 136
TABLE 189 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 137
TABLE 190 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 137
TABLE 191 SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 137
TABLE 192 SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 138
TABLE 193 SPAIN: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 138
TABLE 194 SPAIN: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 138
9.3.6 REST OF EUROPE 139
TABLE 195 ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 139
TABLE 196 ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 139
TABLE 197 ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 139
TABLE 198 ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 140
TABLE 199 ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 140
TABLE 200 ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 140
TABLE 201 ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 140
TABLE 202 ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 141
TABLE 203 ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 141
TABLE 204 ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 141
TABLE 205 ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 142
TABLE 206 ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 142
TABLE 207 ROE: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 142
TABLE 208 ROE: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 142
9.4 ASIA PACIFIC 143
FIGURE 13 ASIA PACIFIC: BLOOD SCREENING MARKET SNAPSHOT 143
TABLE 209 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019
(USD MILLION) 144
TABLE 210 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025
(USD MILLION) 144
TABLE 211 ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION) 144
TABLE 212 ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 145
TABLE 213 ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION) 145
TABLE 214 ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION) 145
TABLE 215 ASIA PACIFIC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 146

10 COMPETITIVE LANDSCAPE (Page No. – 189)
10.1 OVERVIEW
FIGURE 14 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2019
10.2 MARKET SHARE ANALYSIS, 2019
10.2.1 MARKET SHARE ANALYSIS FOR NAT BLOOD SCREENING, 2019
FIGURE 15 NAT BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
10.2.2 MARKET SHARE ANALYSIS FOR TOTAL BLOOD SCREENING, 2019
FIGURE 16 BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
10.3 COMPETITIVE SCENARIO
10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019)
10.3.2 PRODUCT LAUNCHES (2017–2019)
10.3.3 EXPANSIONS (2017–2019)
10.3.4 ACQUISITIONS (2017–2019)
10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
10.4.1 VENDOR INCLUSION CRITERIA
10.4.2 VISIONARY LEADERS
10.4.3 INNOVATORS
10.4.4 DYNAMIC DIFFERENTIATORS
10.4.5 EMERGING COMPANIES
FIGURE 17 BLOOD SCREENING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019

11 COMPANY PROFILES (Page No. – 196)
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1 GRIFOLS
FIGURE 18 GRIFOLS: COMPANY SNAPSHOT (2019)
11.2 F. HOFFMANN-LA ROCHE
FIGURE 19 F. HOFFMAN-LA ROCHE: COMPANY SNAPSHOT (2019)
11.3 ABBOTT LABORATORIES
FIGURE 20 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
11.4 BIOMÉRIEUX
FIGURE 21 BIOMÉRIEUX: COMPANY SNAPSHOT (2018)
11.5 BIO-RAD LABORATORIES
FIGURE 22 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
11.6 BECTON, DICKSON AND COMPANY
FIGURE 23 BECTON, DICKSON AND COMPANY: COMPANY SNAPSHOT (2019)
11.7 DANAHER CORPORATION
FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
11.8 ORTHO CLINICAL DIAGNOSTICS
11.9 SIEMENS HEALTHINEERS
FIGURE 25 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
11.10 THERMO FISHER SCIENTIFIC
FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
11.11 DIASORIN
FIGURE 27 DIASORIN: COMPANY SNAPSHOT (2019)
11.12 GE HEALTHCARE
FIGURE 28 GENERAL ELECTRIC: COMPANY SNAPSHOT (2019)
11.13 MERCK KGAA
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2019)
11.14 PERKINELMER
FIGURE 30 PERKINELMER: COMPANY SNAPSHOT (2019)
11.15 BIO-TECHNE
FIGURE 31 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2019)
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.16 GFE
11.17 TRINITY BIOTECH
11.18 J. MITRA DIAGNOSTICS PVT. LTD.

12 ADJACENT/ RELATED MARKET- IMMUNOASSAY MARKET (Page No. – 233)
12.1 INTRODUCTION
12.2 IMMUNOASSAY MARKET
12.2.1 MARKET DEFINITION
12.2.2 LIMITATIONS
12.2.3 MARKET OVERVIEW
12.3 IMMUNOASSAY MARKET, BY PRODUCT AND SERVICE
TABLE 354 IMMUNOASSAYS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 355 IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
12.3.1 REAGENTS & KITS
TABLE 356 IMMUNOASSAY REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
12.3.1.1 Reagents & Kits Market, By Type
TABLE 357 IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
12.3.1.1.1 ELISA Reagents & Kits
TABLE 358 ELISA REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
12.3.1.1.2 Rapid Test Reagents & Kits
TABLE 359 RAPID TEST REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
12.3.1.1.3 ELISPOT Reagents & Kits
TABLE 360 ELISPOT REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
12.3.1.1.4 Western blot reagents & kits
TABLE 361 WESTERN BLOT REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
12.3.1.1.5 Other reagents & kits
TABLE 362 OTHER REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION)
12.4 ANALYZERS
TABLE 363 IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 364 IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION)
12.4.1 OPEN-ENDED SYSTEMS
TABLE 365 OPEN-ENDED SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
12.4.2 CLOSED-ENDED SYSTEMS

TABLE 366 CLOSED-ENDED SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
12.4.3 IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE

TABLE 367 IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016–2023 (USD MILLION)
12.5 SOFTWARE & SERVICES
TABLE 368 IMMUNOASSAY SOFTWARE & SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION)
12.6 MOLECULAR DIAGNOSTICS MARKET
TABLE 369 MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 370 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
12.7 WESTERN BLOTTING MARKET
TABLE 371 WESTERN BLOTTING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
12.8 IN-VITRO DIAGNOSTICS MARKET
TABLE 372 IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2019–2025 (USD MILLION)

13 APPENDIX (Page No. – 247)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

TABLE 216 ASIA PACIFIC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 146
TABLE 217 ASIA PACIFIC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 146
TABLE 218 ASIA PACIFIC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 147
TABLE 219 ASIA PACIFIC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 147
TABLE 220 ASIA PACIFIC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 147
TABLE 221 ASIA PACIFIC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 148
TABLE 222 ASIA PACIFIC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 148
TABLE 223 ASIA PACIFIC: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 148
TABLE 224 ASIA PACIFIC: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 148
9.4.1 CHINA 149
9.4.1.1 China has a high prevalence of infectious diseases 149
9.4.1.2 COVID-19 Impact Analysis 149
TABLE 225 CHINA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 149
TABLE 226 CHINA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 149
TABLE 227 CHINA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 150
TABLE 228 CHINA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 150
TABLE 229 CHINA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 150
TABLE 230 CHINA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 150
TABLE 231 CHINA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 151
TABLE 232 CHINA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 151
TABLE 233 CHINA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 151
TABLE 234 CHINA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 152
TABLE 235 CHINA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 152
TABLE 236 CHINA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 152
TABLE 237 CHINA: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 152
TABLE 238 CHINA: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 153
9.4.2 JAPAN 153
9.4.2.1 Japan has witnessed an increase in the adoption of advanced blood screening technologies 153
9.4.2.2 COVID-19 Impact Analysis 153
TABLE 239 JAPAN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 153
TABLE 240 JAPAN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 154
TABLE 241 JAPAN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 154
TABLE 242 JAPAN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 154
TABLE 243 JAPAN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 154
TABLE 244 JAPAN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 155
TABLE 245 JAPAN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 155
TABLE 246 JAPAN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 155
TABLE 247 JAPAN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 156
TABLE 248 JAPAN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 156
TABLE 249 JAPAN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 156
TABLE 250 JAPAN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 157
TABLE 251 JAPAN: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 157
TABLE 252 JAPAN: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 157
9.4.3 INDIA 157
9.4.3.1 Increasing number of road accidents will support market growth 157
9.4.3.2 COVID-19 Impact Analysis 158
TABLE 253 INDIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 158
TABLE 254 INDIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 158
TABLE 255 INDIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 159
TABLE 256 INDIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 159
TABLE 257 INDIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 159
TABLE 258 INDIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 159
TABLE 259 INDIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 160
TABLE 260 INDIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 160
TABLE 261 INDIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 160
TABLE 262 INDIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 161
TABLE 263 INDIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 161
TABLE 264 INDIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 161
TABLE 265 INDIA: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 161
TABLE 266 INDIA: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 162
9.4.4 AUSTRALIA 162
9.4.4.1 Rising number of blood donations will propel market growth 162
TABLE 267 AUSTRALIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION) 162
TABLE 268 AUSTRALIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 162
TABLE 269 AUSTRALIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION) 163
TABLE 270 AUSTRALIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION) 163
TABLE 271 AUSTRALIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2016–2019 (USD MILLION) 163
TABLE 272 AUSTRALIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2020–2025 (USD MILLION) 163
TABLE 273 AUSTRALIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 164
TABLE 274 AUSTRALIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 164
TABLE 275 AUSTRALIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 164
TABLE 276 AUSTRALIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 165
TABLE 277 AUSTRALIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 165
TABLE 278 AUSTRALIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 165
TABLE 279 AUSTRALIA: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 165
TABLE 280 AUSTRALIA: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 166
9.4.5 REST OF ASIA PACIFIC 166
TABLE 281 ROAPAC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 166
TABLE 282 ROAPAC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 166
TABLE 283 ROAPAC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 167
TABLE 284 ROAPAC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 167
TABLE 285 ROAPAC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2016–2019 (USD MILLION) 167
TABLE 286 ROAPAC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM,
2020–2025 (USD MILLION) 167
TABLE 287 ROAPAC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2016–2019 (USD MILLION) 168
TABLE 288 ROAPAC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 168
TABLE 289 ROAPAC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 168
TABLE 290 ROAPAC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 169
TABLE 291 ROAPAC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 169
TABLE 292 ROAPAC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 169
TABLE 293 ROAPAC: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 169
TABLE 294 ROAPAC: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 170
9.5 LATIN AMERICA 170
TABLE 295 LATIN AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 170
TABLE 296 LATIN AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 170
TABLE 297 LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION) 171
TABLE 298 LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 171
TABLE 299 LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE,
2016–2019 (USD MILLION) 171
TABLE 300 LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE,
2020–2025 (USD MILLION) 172
TABLE 301 LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 172
TABLE 302 LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 172
TABLE 303 LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 173
TABLE 304 LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 173
TABLE 305 LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 173
TABLE 306 LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 174
TABLE 307 LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 174
TABLE 308 LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 174
TABLE 309 LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 174
TABLE 310 LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 175
9.5.1 BRAZIL 175
9.5.1.1 Increasing incidence of cancer will support the growth of this market 175
TABLE 311 INCIDENCE OF VARIOUS CANCERS IN BRAZIL, 2018 VS. 2025 175
TABLE 312 BRAZIL: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 175
TABLE 313 BRAZIL: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 176
TABLE 314 BRAZIL: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 176
TABLE 315 BRAZIL: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 176
TABLE 316 BRAZIL: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 176
TABLE 317 BRAZIL: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 177
TABLE 318 BRAZIL: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 177
TABLE 319 BRAZIL: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 177
TABLE 320 BRAZIL: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2016–2019 (USD MILLION) 178
TABLE 321 BRAZIL: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE,
2020–2025 (USD MILLION) 178
TABLE 322 BRAZIL: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 178
TABLE 323 BRAZIL: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 179
TABLE 324 BRAZIL: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 179
TABLE 325 BRAZIL: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 179
9.5.2 REST OF LATIN AMERICA 180
TABLE 326 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION) 180
TABLE 327 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 180
TABLE 328 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019 (USD MILLION) 180
TABLE 329 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025 (USD MILLION) 181
TABLE 330 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA,
BY PLATFORM, 2016–2019 (USD MILLION) 181
TABLE 331 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA,
BY PLATFORM, 2020–2025 (USD MILLION) 181
TABLE 332 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 182
TABLE 333 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 182
TABLE 334 REST OF LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET,
BY TYPE, 2016–2019 (USD MILLION) 182
TABLE 335 REST OF LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET,
BY TYPE, 2020–2025 (USD MILLION) 183
TABLE 336 REST OF LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET,
BY PURCHASE TYPE, 2016–2019 (USD MILLION) 183
TABLE 337 REST OF LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET,
BY PURCHASE TYPE, 2020–2025 (USD MILLION) 183
TABLE 338 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2016–2019 (USD MILLION) 183
TABLE 339 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2020–2025 (USD MILLION) 184
9.6 MIDDLE EAST & AFRICA 184
9.6.1 RISING PREVALENCE OF INFECTIOUS DISEASES WILL DRIVE MARKET GROWTH IN THE REGION 184
TABLE 340 MEA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016–2019
(USD MILLION) 184
TABLE 341 MEA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2020–2025
(USD MILLION) 185
TABLE 342 MEA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2016–2019
(USD MILLION) 185
TABLE 343 MEA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2020–2025
(USD MILLION) 185
TABLE 344 MEA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2016–2019 (USD MILLION) 185
TABLE 345 MEA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2020–2025 (USD MILLION) 186
TABLE 346 MEA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION) 186
TABLE 347 MEA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 186
TABLE 348 MEA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION) 187
TABLE 349 MEA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2020–2025 (USD MILLION) 187
TABLE 350 MEA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2016–2019 (USD MILLION) 187
TABLE 351 MEA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2020–2025 (USD MILLION) 188
TABLE 352 MEA: BLOOD SCREENING MARKET, BY END USER, 2016–2019
(USD MILLION) 188
TABLE 353 MEA: BLOOD SCREENING MARKET, BY END USER, 2020–2025
(USD MILLION) 188
10 COMPETITIVE LANDSCAPE 189
10.1 OVERVIEW 189
FIGURE 14 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2019 189
10.2 MARKET SHARE ANALYSIS, 2019 190
10.2.1 MARKET SHARE ANALYSIS FOR NAT BLOOD SCREENING, 2019 190
FIGURE 15 NAT BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 190
10.2.2 MARKET SHARE ANALYSIS FOR TOTAL BLOOD SCREENING, 2019 191
FIGURE 16 BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 191
10.3 COMPETITIVE SCENARIO 192
10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019) 192
10.3.2 PRODUCT LAUNCHES (2017–2019) 192
10.3.3 EXPANSIONS (2017–2019) 193
10.3.4 ACQUISITIONS (2017–2019) 193
10.4 COMPETITIVE LEADERSHIP MAPPING (2019) 194
10.4.1 VENDOR INCLUSION CRITERIA 194
10.4.2 VISIONARY LEADERS 194
10.4.3 INNOVATORS 194
10.4.4 DYNAMIC DIFFERENTIATORS 194
10.4.5 EMERGING COMPANIES 194
FIGURE 17 BLOOD SCREENING MARKET (GLOBAL) COMPETITIVE LEADERSHIP
MAPPING, 2019 195
11 COMPANY PROFILES 196
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1 GRIFOLS 196
FIGURE 18 GRIFOLS: COMPANY SNAPSHOT (2019) 196
11.2 F. HOFFMANN-LA ROCHE 199
FIGURE 19 F. HOFFMAN-LA ROCHE: COMPANY SNAPSHOT (2019) 199
11.3 ABBOTT LABORATORIES 202
FIGURE 20 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 202
11.4 BIOMÉRIEUX 205
FIGURE 21 BIOMÉRIEUX: COMPANY SNAPSHOT (2018) 205
11.5 BIO-RAD LABORATORIES 207
FIGURE 22 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019) 207
11.6 BECTON, DICKSON AND COMPANY 210
FIGURE 23 BECTON, DICKSON AND COMPANY: COMPANY SNAPSHOT (2019) 210
11.7 DANAHER CORPORATION 212
FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 212
11.8 ORTHO CLINICAL DIAGNOSTICS 214
11.9 SIEMENS HEALTHINEERS 215
FIGURE 25 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019) 215
11.10 THERMO FISHER SCIENTIFIC 217
FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019) 217
11.11 DIASORIN 219
FIGURE 27 DIASORIN: COMPANY SNAPSHOT (2019) 219
11.12 GE HEALTHCARE 222
FIGURE 28 GENERAL ELECTRIC: COMPANY SNAPSHOT (2019) 222
11.13 MERCK KGAA 224
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2019) 224
11.14 PERKINELMER 226
FIGURE 30 PERKINELMER: COMPANY SNAPSHOT (2019) 226
11.15 BIO-TECHNE 228
FIGURE 31 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2019) 228
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.16 GFE 230
11.17 TRINITY BIOTECH 231
11.18 J. MITRA DIAGNOSTICS PVT. LTD. 232
12 ADJACENT/ RELATED MARKET- IMMUNOASSAY MARKET 233
12.1 INTRODUCTION 233
12.2 IMMUNOASSAY MARKET 233
12.2.1 MARKET DEFINITION 233
12.2.2 LIMITATIONS 233
12.2.3 MARKET OVERVIEW 233
12.3 IMMUNOASSAY MARKET, BY PRODUCT AND SERVICE 234
TABLE 354 IMMUNOASSAYS MARKET, BY REGION, 2016–2023 (USD MILLION) 234
TABLE 355 IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016–2023
(USD MILLION) 235
12.3.1 REAGENTS & KITS 235
TABLE 356 IMMUNOASSAY REAGENTS & KITS MARKET, BY REGION, 2016–2023
(USD MILLION) 235
12.3.1.1 Reagents & Kits Market, By Type 236
TABLE 357 IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016–2023
(USD MILLION) 236
12.3.1.1.1 ELISA Reagents & Kits 236
TABLE 358 ELISA REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION) 237
12.3.1.1.2 Rapid Test Reagents & Kits 237
TABLE 359 RAPID TEST REAGENTS & KITS MARKET, BY REGION, 2016–2023
(USD MILLION) 238
12.3.1.1.3 ELISPOT Reagents & Kits 238
TABLE 360 ELISPOT REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION) 238
12.3.1.1.4 Western blot reagents & kits 239
TABLE 361 WESTERN BLOT REAGENTS & KITS MARKET, BY REGION, 2016–2023
(USD MILLION) 239
12.3.1.1.5 Other reagents & kits 240
TABLE 362 OTHER REAGENTS & KITS MARKET, BY REGION, 2016–2023 (USD MILLION) 240
12.4 ANALYZERS 241
TABLE 363 IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2016–2023
(USD MILLION) 241
TABLE 364 IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 241
12.4.1 OPEN-ENDED SYSTEMS 242
TABLE 365 OPEN-ENDED SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION) 242
12.4.2 CLOSED-ENDED SYSTEMS 242
TABLE 366 CLOSED-ENDED SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION) 242
12.4.3 IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE 243
TABLE 367 IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016–2023 (USD MILLION) 243
12.5 SOFTWARE & SERVICES 243
TABLE 368 IMMUNOASSAY SOFTWARE & SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION) 244
12.6 MOLECULAR DIAGNOSTICS MARKET 244
TABLE 369 MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023
(USD MILLION) 244
TABLE 370 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 245
12.7 WESTERN BLOTTING MARKET 245
TABLE 371 WESTERN BLOTTING MARKET SIZE, BY PRODUCT, 2014–2021
(USD MILLION) 245
12.8 IN-VITRO DIAGNOSTICS MARKET 246
TABLE 372 IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2019–2025
(USD MILLION) 246

13 APPENDIX 247
13.1 DISCUSSION GUIDE 247
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 250
13.3 AVAILABLE CUSTOMIZATIONS 252
13.4 RELATED REPORTS 252
13.5 AUTHOR DETAILS 253

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[血液スクリーニングの世界市場予測:技術別(核酸増幅、(リアルタイムPCR)、ELISA(化学発光免疫測定法)、迅速検査、ウエスタンブロット)、製品別(機器、試薬&キット、ソフトウェア)、エンドユーザー別(血液銀行、病院)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆